Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
23.60
+1.43 (6.45%)
At close: Mar 9, 2026, 4:00 PM EDT
23.54
-0.06 (-0.25%)
After-hours: Mar 9, 2026, 5:14 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $365.56 million as of March 9, 2026. Its market cap has increased by 42.17% in one year.
Market Cap
365.56M
Enterprise Value
99.98M
1-Year Change
42.17%
Ranking
Category
Stock Price
$23.60
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $365.56M, an increase of 88.79%. That is a compound annual growth rate of 33.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 343.41M | 7.62% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 361.84M |
| Bicycle Therapeutics | 360.71M |
| Absci | 357.88M |
| Aura Biosciences | 355.62M |
| Immuneering | 344.16M |
| Climb Bio | 342.97M |
| Foghorn Therapeutics | 338.60M |
| Opus Genetics | 337.23M |